Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Travel Vaccines Market: By Composition: Mono Vaccines, Combination Vaccines; By Disease: Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Manufacturing Process; Competitive Landscape; Industry Events and Developments
Global Travel Vaccines Market Outlook
The global travel vaccines market attained a value of USD 5.4 billion in 2020. By 2026, the market is expected to reach USD 7.7 billion, while registering a CAGR of 6.1% during the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of the composition, the combination vaccines segment accounted for the majority of the global travel vaccines market share, as it protects the travellers against multiple diseases. Based on the disease, the hepatitis A segment dominated the industry in 2020. Regionally, North America held the most significant market share in 2020, on account of the presence of a large number of companies in the region who are introducing a superior range of travel vaccines.
Properties and Applications
Travel vaccines are immunization shots, which travellers get before visiting any region across the world. These vaccines build immunity against viral as well as microbial invasions while improving the overall health of the individual. In addition, the body responds to the vaccination by making antibodies and protecting it against a situation where there is an exposure to the disease. These immunizations must be taken at least 4 to 6 weeks before travelling as this gives enough time for the immunization to start working efficiently.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major compositions of the global travel vaccines market are:
- Mono Vaccines
- Combination Vaccines
The industry can be broadly categorised on the basis of the diseases segment into:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
The EMR report looks into the regional markets in the global travel vaccines market like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The rising prevalence of infectious and travel-related diseases, such as Japanese encephalitis, meningitis, diphtheria, and yellow fever, is one of the prime factors that are driving the growth of the industry. In addition to this, the rising globalization and reduced international airfares have led to an increase in international tourism. Consequently, travel vaccines have now become an important requirement in an international travellers’ list, with its market witnessing a significant growth globally. Several combination vaccines have also been introduced for travellers, which protect against more than one disease, thus, supporting the industry growth as they increasingly gain popularity. Additionally, governments across several countries are heavily investing in the promotion of the use of these vaccines. For instance, the Ministry of Health in the Kingdom of Saudi Arabia (KSA) requires that all travellers arriving for Hajj and Umrah from other countries must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements, and increasing incidences of life-threatening infectious diseases.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global travel vaccines market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- GlaxoSmithKline plc.
- Merck & Co., Inc
- Sanofi
- Pfizer Inc.
- CSL Limited
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Composition, Disease, Region |
| Breakup by Composition | Mono Vaccines, Combination Vaccines |
| Breakup by Disease | Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | GlaxoSmithKline plc., Merck & Co., Inc, Sanofi, Pfizer Inc., CSL Limited, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Travel Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Global Travel Vaccines Historical Market (2018-2022)
8.3 Global Travel Vaccines Market Forecast (2023-2028)
8.4 Global Travel Vaccines Market by Composition
8.4.1 Mono Vaccines
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Combination Vaccines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Travel Vaccines Market by Disease
8.5.1 Hepatitis A
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 DPT
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Yellow Fever
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Typhoid
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Hepatitis B
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Measles and Mumps
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2018-2022)
8.5.6.3 Forecast Trend (2023-2028)
8.5.7 Rabies
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2018-2022)
8.5.7.3 Forecast Trend (2023-2028)
8.5.8 Meningococcal
8.5.8.1 Market Share
8.5.8.2 Historical Trend (2018-2022)
8.5.8.3 Forecast Trend (2023-2028)
8.5.9 Varicella
8.5.9.1 Market Share
8.5.9.2 Historical Trend (2018-2022)
8.5.9.3 Forecast Trend (2023-2028)
8.5.10 Japanese Encephalitis
8.5.10.1 Market Share
8.5.10.2 Historical Trend (2018-2022)
8.5.10.3 Forecast Trend (2023-2028)
8.5.11 Others
8.6 Global Travel Vaccines Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Market (2018-2022)
9.3.2 Market Forecast (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Manufacturing Process
12.1 Detailed Process Flow
12.2 Operations Involved
12.3 Mass Balance
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players’ Market Share
13.3 Company Profiles
13.3.1 GlaxoSmithKline plc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Demographic Reach and Achievements
13.3.1.4 Financial Summary
13.3.1.5 Certifications
13.3.2 Merck & Co., Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Demographic Reach and Achievements
13.3.2.4 Financial Summary
13.3.2.5 Certifications
13.3.3 Sanofi
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Demographic Reach and Achievements
13.3.3.4 Financial Summary
13.3.3.5 Certifications
13.3.4 Pfizer Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Demographic Reach and Achievements
13.3.4.4 Financial Summary
13.3.4.5 Certifications
13.3.5 CSL Limited
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Demographic Reach and Achievements
13.3.5.4 Financial Summary
13.3.5.5 Certifications
13.3.6 Others
14 Industry Events and Developments
List of Key Figures and Tables
1. Global Travel Vaccines Market: Key Industry Highlights, 2018 and 2028
2. Global Travel Vaccines Historical Market: Breakup by Composition (USD Million), 2018-2022
3. Global Travel Vaccines Market Forecast: Breakup by Composition (USD Million), 2023-2028
4. Global Travel Vaccines Historical Market: Breakup by Disease (USD Million), 2018-2022
5. Global Travel Vaccines Market Forecast: Breakup by Disease (USD Million), 2023-2028
6. Global Travel Vaccines Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Travel Vaccines Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Travel Vaccines Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Travel Vaccines Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Travel Vaccines Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Travel Vaccines Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Travel Vaccines Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Travel Vaccines Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Travel Vaccines Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Travel Vaccines Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Travel Vaccines Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Travel Vaccines Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Travel Vaccines Market Structure
Key Questions Answered in the Report
In 2020, the global travel vaccines market attained a value of nearly USD 5.4 billion.
The market is projected to grow at a CAGR of 6.1% between 2021 and 2026.
By 2026, the market is estimated to attain a value of USD 7.7 billion.
The major drivers of the industry, such as rising globalization, rising prevalence of infectious and travel-related diseases such as Japanese encephalitis, meningitis, diphtheria, and yellow fever, are expected to aid the market growth.
The key industry trend guiding the growth of the travel vaccines market includes the promotion of different vaccines by the government bodies of several countries.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The combination vaccines segment is the leading travel vaccine composition in the industry.
The hepatitis A segment is the dominant disease-type in the industry.
The major players in the industry are GlaxoSmithKline plc., Merck & Co., Inc, Sanofi, Pfizer Inc., and CSL Limited, among others.
Analyst Review
The global travel vaccines market attained a value of USD 5.4 billion in 2020 driven by the growing prevalence of infectious and travel-related diseases. Aided by technological advancements and favourable government regulations, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 6.1% to reach a value of USD 7.7 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its composition, the combination vaccines segment is the major travel vaccine composition in the industry. On the basis of disease, hepatitis A is the leading disease-type in the industry. The major regional markets for travel vaccines are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include GlaxoSmithKline plc., Merck & Co., Inc, Sanofi, Pfizer Inc., CSL Limited, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER